MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade.
Saved in:
| Title: | MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. |
|---|---|
| Authors: | Mukherjee N; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA., Katsnelson E; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA., Brunetti TM; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Michel K; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA., Couts KL; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA., Lambert KA; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA., Robinson WA; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA., McCarter MD; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA., Norris DA; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA.; Department of Veterans Affairs Medical Center, Dermatology Section, Denver, CO, 80220, USA., Tobin RP; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA. Richard.Tobin@cuanschutz.edu., Shellman YG; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA. Yiqun.shellman@CUAnschutz.edu.; University of Colorado Anschutz Medical Campus, Gates Center for Regenerative Medicine, Aurora, CO, 80045, USA. Yiqun.shellman@CUAnschutz.edu. |
| Source: | Cell death & disease [Cell Death Dis] 2024 Mar 08; Vol. 15 (3), pp. 198. Date of Electronic Publication: 2024 Mar 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38459020 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mukherjee+N%22">Mukherjee N</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Katsnelson+E%22">Katsnelson E</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Brunetti+TM%22">Brunetti TM</searchLink>; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Michel+K%22">Michel K</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Couts+KL%22">Couts KL</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Lambert+KA%22">Lambert KA</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Robinson+WA%22">Robinson WA</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22McCarter+MD%22">McCarter MD</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA.<br /><searchLink fieldCode="AU" term="%22Norris+DA%22">Norris DA</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA.; Department of Veterans Affairs Medical Center, Dermatology Section, Denver, CO, 80220, USA.<br /><searchLink fieldCode="AU" term="%22Tobin+RP%22">Tobin RP</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA. Richard.Tobin@cuanschutz.edu.<br /><searchLink fieldCode="AU" term="%22Shellman+YG%22">Shellman YG</searchLink>; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA. Yiqun.shellman@CUAnschutz.edu.; University of Colorado Anschutz Medical Campus, Gates Center for Regenerative Medicine, Aurora, CO, 80045, USA. Yiqun.shellman@CUAnschutz.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2024 Mar 08; Vol. 15 (3), pp. 198. <i>Date of Electronic Publication: </i>2024 Mar 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38459020 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41419-024-06524-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 198 Titles: – TitleFull: MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mukherjee N – PersonEntity: Name: NameFull: Katsnelson E – PersonEntity: Name: NameFull: Brunetti TM – PersonEntity: Name: NameFull: Michel K – PersonEntity: Name: NameFull: Couts KL – PersonEntity: Name: NameFull: Lambert KA – PersonEntity: Name: NameFull: Robinson WA – PersonEntity: Name: NameFull: McCarter MD – PersonEntity: Name: NameFull: Norris DA – PersonEntity: Name: NameFull: Tobin RP – PersonEntity: Name: NameFull: Shellman YG IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 03 Text: 2024 Mar 08 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-4889 Numbering: – Type: volume Value: 15 – Type: issue Value: 3 Titles: – TitleFull: Cell death & disease Type: main |
| ResultId | 1 |